Porvair (PRV) CMD 2026 summary
Event summary combining transcript, slides, and related documents.
CMD 2026 summary
19 Oct, 2026Strategy and operating model
Next phase shifts from 20 years of compounding toward accelerated growth, with sharper focus on margin, cash and returns; historical revenue CAGR was 8% and adjusted EPS CAGR 13%.
Model pairs specialist businesses, customer proximity and front-line autonomy with central direction on strategy, capital allocation, M&A, performance standards and shared expertise.
2025 changes included a new Executive Committee, strategy review, clearer mandates, stronger customer and operational focus, and improved M&A capability; 2026 priorities include scaling execution and integration.
Portfolio shifted toward Grow businesses at ~54% of turnover from ~38% in FY24; Stabilise fell to ~4% from ~18%, while Improve was ~42% versus ~44%.
Priorities include customer-centric commercial excellence, operational improvement, innovation, scalable leadership, active portfolio management and value-accretive M&A.
Financial framework and capital allocation
Medium-term targets: 10%+ total revenue CAGR, including acquisitions; mid-single-digit organic constant-currency growth; adjusted operating margin of 16%-18% by FY31; adjusted EPS growth of 10%-20%.
Targets include operating cash flow conversion of 85%+, ROIC of 18%+ and leverage below 1.5x; leverage up to 2.0x may be considered for compelling strategic rationale.
Operating cash flow conversion exceeded 90% in each of the last five years; five-year free cash flow was ~£85m, alongside £55m for acquisitions and CapEx and £13m in dividends.
Capital allocation prioritizes organic investment, targeted acquisitions and progressive dividends; additional returns require consistent surplus cash. Growth CapEx is expected to rise toward ~4% of revenue.
Adjusted operating margin increased 80 bps to 13.5% in 2025; progression toward 16%-18% is expected to be non-linear, supported by portfolio management, commercial excellence and operational improvement.
Trading and outlook
Ten months to 30 Sep 2026 showed continued strong trading and a strong Q4 start, with organic revenue growth in all three divisions.
Adjusted operating profit margin was slightly ahead of the prior-year ten-month period; net cash remained positive excluding lease liabilities after three acquisitions.
FY26 trading was expected slightly ahead of market expectations, supported by diversified customers, recurring revenue and disciplined operations.
Latest events from Porvair
- Full-year trading set to surpass expectations, driven by acquisitions and 14% revenue growth.PRV
Q3 2026 TU - Record H1 2026 revenue and profit, driven by acquisitions and strong core market demand.PRV
H1 2026 - Record results, margin gains, and Drache acquisition drive growth into 2026 amid uncertainty.PRV
H2 2025 - Revenue and EPS up 3%, strong cash, industrial and lab growth, macro headwinds persist.PRV
H1 2025 - Revenue up 5% with strong aerospace and petrochemical demand; positive H2 outlook.PRV
H1 2024 - Trading remains on track; new CEO appointed and outlook unchanged.PRV
Trading Update - Record results with strong aerospace growth, robust cash, and steady long-term outlook.PRV
H2 2024